APA (7th ed.) Citation

Zamora, C., Diaz-Torne, C., Ortiz, M. A., Moya, P., Park, H. S., Pitarch, C., . . . Vidal, S. (2025). Platelet-Derived Soluble CD40L and Its Impact on Immune Modulation and Anti-IL6R Antibody Treatment Outcome in Rheumatoid Arthritis. Cells (2073-4409), 14(9), 625. https://doi.org/10.3390/cells14090625

Chicago Style (17th ed.) Citation

Zamora, Carlos, et al. "Platelet-Derived Soluble CD40L and Its Impact on Immune Modulation and Anti-IL6R Antibody Treatment Outcome in Rheumatoid Arthritis." Cells (2073-4409) 14, no. 9 (2025): 625. https://doi.org/10.3390/cells14090625.

MLA (9th ed.) Citation

Zamora, Carlos, et al. "Platelet-Derived Soluble CD40L and Its Impact on Immune Modulation and Anti-IL6R Antibody Treatment Outcome in Rheumatoid Arthritis." Cells (2073-4409), vol. 14, no. 9, 2025, p. 625, https://doi.org/10.3390/cells14090625.